Research Study Opportunity: Caregivers of Loved Ones with Alzheimer’s-related Apathy

  • Event
Published on:
IQVIA logo

Alzheimer’s Disease Research, a BrightFocus Foundation program, is partnering with IQVIA™, a healthcare research firm, who is currently conducting a research project with caregivers of individuals ages 50 – 85, who have been diagnosed with dementia-related apathy by a healthcare provider. 

The research will involve participating in two telephone interviews: 

  • The first interview will last about 60 minutes. In appreciation of your time, IQVIA is offering a $125 stipend.  

  • The second interview will last about 90 minutes, and you will need access to an internet-enabled computer or tablet. To thank you for your time, IQVIA is offering a $175 stipend. 

The research will focus on understanding the experience of people with dementia-related apathy, how it presents and how it impacts their lives, from your perspective as their caregiver. This research may help improve how the patient experience is accounted for in clinical trials for new treatments.

Interviews are currently being scheduled and we have a range of different time slots to fit your schedule.

person holding phone

The study is strictly for research purposes; there will be absolutely no sales or promotional activities.

The aim of this research is to gain your views and is not in any way promotional.

If you are interested or have any questions, please contact Sofia López from IQVIA by clicking the button below.

BrightFocus Foundation is a premier global nonprofit funder of research and provides expert information to defeat Alzheimer’s, macular degeneration and glaucoma. BrightFocus is currently supporting a $65 million global portfolio of more than 260 projects. International grant applications are now available on brightfocus.org.    

IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique innovations and actionable insights.

Don't miss out.

Receive Alzheimer's breakthrough news, research updates, and inspiring stories.